Skip to content

Advertisement

Gynecologic Oncology Research and Practice

Articles

Sort by
Previous Page Page 1 of 3 Next Page
  1. Content type: Research

    Gynaecological cancers may be the sentinel malignancy in women who carry a mutation in BRCA1 or 2, a mis-match repair gene causing Lynch Syndrome or other genes. Despite published guidelines for referral to a ...

    Authors: Hanoon P. Pokharel, Neville F. Hacker and Lesley Andrews

    Citation: Gynecologic Oncology Research and Practice 2018 5:2

    Published on:

  2. Content type: Review

    Combretastatin A4-phosphate (CA4P) is a vascular-disrupting agent (VDA) in clinical development for the treatment of ovarian and other cancers. In contrast to antiangiogenic agents, such as bevacizumab, which ...

    Authors: Rachel Grisham, Bonnie Ky, Krishnansu S. Tewari, David J. Chaplin and Joan Walker

    Citation: Gynecologic Oncology Research and Practice 2018 5:1

    Published on:

  3. Content type: Research

    In Ethiopia, cervical cancer is ranked as the second most common type of cancer in women and it is about 8 times more common in HIV infected women. However, data on knowledge of HIV infected women regarding ce...

    Authors: Daniel Asfaw Erku, Adeladlew Kassie Netere, Amanual Getnet Mersha, Sileshi Ayele Abebe, Abebe Basazn Mekuria and Sewunet Admasu Belachew

    Citation: Gynecologic Oncology Research and Practice 2017 4:20

    Published on:

  4. Content type: Review

    Endometrial cancer is the most common gynecologic malignancy in the United States, accounting for 6% of cancers in women. In 2017, an estimated 61,380 women were diagnosed with endometrial cancer, and approxim...

    Authors: Vicky Makker, Angela K. Green, Robert M. Wenham, David Mutch, Brittany Davidson and David Scott Miller

    Citation: Gynecologic Oncology Research and Practice 2017 4:19

    Published on:

  5. Content type: Review

    Poly (ADP-ribose) polymerases (PARPs) are an important family of nucleoproteins highly implicated in DNA damage repair. Among the PARP families, the most studied are PARP1, PARP2 and PARP 3. PARP1 is found to ...

    Authors: Mekonnen Sisay and Dumessa Edessa

    Citation: Gynecologic Oncology Research and Practice 2017 4:18

    Published on:

  6. Content type: Research

    While many of these agents have been compared in prospective clinical trials, the gemcitabine/platinumbased regimens have not been compared in a prospective, randomized clinical trial. While bothgemcitabine/ca...

    Authors: Tran N. Le, Rachel E. Harvey, Christine K. Kim, Jubilee Brown, Robert L. Coleman and Judith A. Smith

    Citation: Gynecologic Oncology Research and Practice 2017 4:16

    Published on:

  7. Content type: Review

    Clear cell carcinoma and endometrioid adenocarcinoma are histologic subtypes of ovarian and uterine cancer that demonstrate unique clinical behavior but share common underlying genomic aberrations and oncogeni...

    Authors: Jill K. Alldredge and Ramez N. Eskander

    Citation: Gynecologic Oncology Research and Practice 2017 4:17

    Published on:

  8. Content type: Research

    Although cervical cancer is preventable, it is still the second leading cause of cancer deaths among women in the world. Further, it is estimated that around 5–10% of hospital admissions are due to drug relate...

    Authors: Amsalu Degu, Peter Njogu, Irene Weru and Peter Karimi

    Citation: Gynecologic Oncology Research and Practice 2017 4:15

    Published on:

  9. Content type: Research

    Preparation in the business of medicine is reported to be poor across a number of specialties. No data exist about such preparation in gynecologic oncology training programs. Our objectives were to evaluate cu...

    Authors: Matthew Schlumbrecht, John Siemon, Guillermo Morales, Marilyn Huang and Brian Slomovitz

    Citation: Gynecologic Oncology Research and Practice 2017 4:14

    Published on:

  10. Content type: Research

    Due to the significant morbidity and mortality associated with placenta percreta, alternative management options are needed. Beginning in 2005, our institution implemented a multidisciplinary strategy to patie...

    Authors: Paula S. Lee, Samantha Kempner, Michael Miller, Jennifer Dominguez, Chad Grotegut, Jessie Ehrisman, Rebecca Previs, Laura J. Havrilesky, Gloria Broadwater, Sarah C. Ellestad and Angeles Alvarez Secord

    Citation: Gynecologic Oncology Research and Practice 2017 4:11

    Published on:

  11. Content type: Research

    To determine the cost-effectiveness of transversus abdominis plane block with liposomal bupivacaine (TAP) compared to oral opioids alone for acute postoperative pain after laparoscopic hysterectomy for early e...

    Authors: Brandon-Luke L. Seagle, Emily S. Miller, Anna E. Strohl, Anna Hoekstra and Shohreh Shahabi

    Citation: Gynecologic Oncology Research and Practice 2017 4:12

    Published on:

  12. Content type: Review

    Survival of patients with advanced, recurrent, or metastatic human papillomavirus (HPV)-associated cancer is suboptimal despite the availability of various treatment modalities. The recently developed bacteria...

    Authors: Brett Miles, Howard P. Safran and Bradley J. Monk

    Citation: Gynecologic Oncology Research and Practice 2017 4:10

    Published on:

  13. Content type: Review

    Immune responses to the facultative intracellular bacterium Listeria monocytogenes (Lm) are robust and well characterized. Utilized for decades as a model of host-disease immunology, Lm is well suited for use as ...

    Authors: Brett A. Miles, Bradley J. Monk and Howard P. Safran

    Citation: Gynecologic Oncology Research and Practice 2017 4:9

    Published on:

  14. Content type: Erratum

    Authors: Dorcas Obiri-Yeboah, Yaw Adu-Sarkodie, Florencia Djigma, Kafui Akakpo, Ebenezer Aniakwa-Bonsu, Daniel Amoako-Sakyi, Jacques Simpore and Philippe Mayaud

    Citation: Gynecologic Oncology Research and Practice 2017 4:8

    Published on:

    The original article was published in Gynecologic Oncology Research and Practice 2017 4:5

  15. Content type: Review

    Bevacizumab is an important component in the treatment of various cancers, and despite guidelines recommending its use in both ovarian and cervical cancer, patient access to bevacizumab and other angiogenesis ...

    Authors: Bradley J. Monk, Warner K. Huh, Julie Ann Rosenberg and Ira Jacobs

    Citation: Gynecologic Oncology Research and Practice 2017 4:7

    Published on:

  16. Content type: Research

    Palliative systemic treatment in elderly gynaecological cancer patients remains a major challenge. In recurrent ovarian cancer (ROC), treosulfan an active alkylating drug showed similar cytotoxicity whether as...

    Authors: Radoslav Chekerov, Philipp Harter, Stefan Fuxius, Lars Christian Hanker, Linn Woelber, Lothar Müller, Peter Klare, Wolfgang Abenhardt, Yoana Nedkova, Isil Yalcinkaya, Georg Heinrich, Harald Sommer, Sven Mahner, Pauline Wimberger, Dominique Koensgen-Mustea, Rolf Richter…

    Citation: Gynecologic Oncology Research and Practice 2017 4:6

    Published on:

  17. Content type: Research

    Modern cervical cancer screening increasingly relies on the use of molecular techniques detecting high-risk oncogenic human papillomavirus (hr-HPV). A major challenge for developing countries like Ghana has be...

    Authors: Dorcas Obiri-Yeboah, Yaw Adu-Sarkodie, Florencia Djigma, Kafui Akakpo, Ebenezer Aniakwa-Bonsu, Daniel Amoako-Sakyi, Jacques Simpore and Philippe Mayaud

    Citation: Gynecologic Oncology Research and Practice 2017 4:5

    Published on:

    The Erratum to this article has been published in Gynecologic Oncology Research and Practice 2017 4:8

  18. Content type: Review

    Until recently our knowledge of a genetic contribution to ovarian cancer focused almost exclusively on mutations in the BRCA1/2 genes. However, through germline and tumor sequencing an understanding of the larger...

    Authors: Melissa K. Frey and Bhavana Pothuri

    Citation: Gynecologic Oncology Research and Practice 2017 4:4

    Published on:

  19. Content type: Case Report

    Nivolumab is an immune checkpoint inhibitor specific for the programmed death 1 (PD-1) receptor that has led to clinical responses in many cancer types. Identifying biomarkers predictive of response to PD-1 bl...

    Authors: Sarah E. Paraghamian, Teresa C. Longoria and Ramez N. Eskander

    Citation: Gynecologic Oncology Research and Practice 2017 4:3

    Published on:

  20. Content type: Review

    Merkel cell carcinoma is a rare and aggressive neoplasm originating from mechanoreceptor Merkel cells of the stratum basale of the epidermis. Cases affecting the vulva are exceedingly rare, with the currently ...

    Authors: Austin Huy Nguyen, Ahmed I. Tahseen, Adam M. Vaudreuil, Gabriel C. Caponetti and Christopher J. Huerter

    Citation: Gynecologic Oncology Research and Practice 2017 4:2

    Published on:

  21. Content type: Research

    The National Comprehensive Cancer Network (NCCN) and the Society of Gynecologic Oncology (SGO) recommend lymph node sampling (LNS) as a key component in the surgical staging of high-grade endometrial cancer. O...

    Authors: Jonathan R. Foote, Stephanie Gaillard, Gloria Broadwater, Julie A. Sosa, Brittany Davidson, Mohamed A. Adam, Angeles Alvarez Secord, Monica B. Jones, Junzo Chino and Laura J. Havrilesky

    Citation: Gynecologic Oncology Research and Practice 2017 4:1

    Published on:

  22. Content type: Review

    Endometrial carcinoma (EC) is the fourth most common cancer in women in the developed world. Classification of ECs by histomorphologic criteria has limited reproducibility and better tools are needed to distin...

    Authors: A. Talhouk and J. N. McAlpine

    Citation: Gynecologic Oncology Research and Practice 2016 3:14

    Published on:

  23. Content type: Research

    Genetic testing for an inherited susceptibility to cancer is an emerging technology in medical practice. Little information is currently available about physicians’ attitudes towards these tests in developing ...

    Authors: Hanoon P Pokharel, Neville F Hacker and Lesley Andrews

    Citation: Gynecologic Oncology Research and Practice 2016 3:12

    Published on:

  24. Content type: Research

    Chemotherapy plays a role in the treatment of endometrioid endometrial cancer (EEC); however, tumor grade may affect response. Our objective was to evaluate associations between tumor grade and in vitro chemor...

    Authors: Brittany A. Davidson, Jonathan Foote, Stacey L. Brower, Chunqiao Tian, Laura J. Havrilesky and Angeles Alvarez Secord

    Citation: Gynecologic Oncology Research and Practice 2016 3:13

    Published on:

Previous Page Page 1 of 3 Next Page

2016 Journal Metrics

  • Speed
    27 days from submission to first decision
    17 days from acceptance to publication

    Usage 
    41,447 Downloads
    1194.0 Usage Factor

    Social Media Impact
    10 Mentions

Advertisement